ࡱ> ;< l \pThe Free Software Foundation B=PF0*8X@"1 Helvetica1Courier1 Courier New1 Courier New1 Helvetica$#,##0_);($#,##0)$#,##0_);[Red]($#,##0)$#,##0.00_);($#,##0.00)$#,##0.00_);[Red]($#,##0.00)-**_($* #,##0_);_($* (#,##0);_($* "-"_);_(@_)*)'_(* #,##0_);_(* (#,##0);_(* "-"_);_(@_)5,2_($* #,##0.00_);_($* (#,##0.00);_($* "-"??_);_(@_)2+/_(* #,##0.00_);_(* (#,##0.00);_(* "-"??_);_(@_)2$#,##0.00;[Red]$#,##0.003$#,##0.00;[Red]($#,##0.00)4$#,##0;[Red]($#,##00)50.00%;[Red](0.00%)6 0%;[Red](0%)7#,##0.00;[Red](#,##0.00)8#,##0;[Red](#,##0)                + ) , *   Ј ~~ ؈ ~~#؈ ~~ ؈ ~~7#܈ ~~4#܈ ~~8#܈ ~~<#܈ ~~3#܈ ~~83ffff̙̙3f3fff3f3f33333f33&Item 701 Regulation FD Disclosu EXHIBIT INDEX Balance Sheet4Income Statement"9CONSOLIDATED BALANCE SHEETSU Cash Flows &[CONSOLIDATED BALANCE (1) l  7  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/?? EXHIBIT INDEX Balance SheetIncome StatementCONSOLIDATED BALANCE SHEETS Cash FlowsCONSOLIDATED BALANCE (1)U } $ } }  } :      TherapeuticsMD, Inc. 8-K 11/06/2017+#Item 7.01 Regulation FD Disclosure. (d) Exhibits.       Exhibit    Number  Description       fffffX@0 (Press Release from TherapeuticsMD, Inc.,80dated November 6, 2017, entitled ?TherapeuticsMD.&Announces Third Quarter 2017 Financial Results.?X@0(Press Release from TherapeuticsMD, Inc.,80dated November 6, 2017, entitled ?TherapeuticsMD/'Announces Plan to Resubmit the New Drug"Application for TX-004HR.?$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/<th\ xH4m l<0$=PF0*8X> @ l  }  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!Item 701 Regulation FD Disclosu Balance SheetIncome StatementCONSOLIDATED BALANCE SHEETS Cash FlowsCONSOLIDATED BALANCE (1)U } I } :      TherapeuticsMD, Inc. 8-K 11/06/2017 EXHIBIT INDEX Exhibit  Number  Description   fffffX@0 (Press Release from TherapeuticsMD, Inc., 8 0dated November 6, 2017, entitled ?TherapeuticsMD.&Announces Third Quarter 2017 Financial Results.?X@0(Press Release from TherapeuticsMD, Inc.,80dated November 6, 2017, entitled ?TherapeuticsMD/'Announces Plan to Resubmit the New Drug"Application for TX-004HR.?$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/:~rZ;l. g(=PF0*8X> @ l  6)3  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!Item 701 Regulation FD Disclosu EXHIBIT INDEXIncome StatementCONSOLIDATED BALANCE SHEETS Cash FlowsCONSOLIDATED BALANCE (1)U } I;} $ } y} $ } y} $ 6                                 TherapeuticsMD, Inc. 8-K 11/06/2017 Balance SheetSeptember 30, 2017December 31, 2016    (Unaudited)        ASSETS Current Assets:         Cash ~ [#  ~ V4\ -%Accounts receivable, net of allowancefor doubtful accounts0( of $377,929 and $376,374, respectively~  ~ n Inventory~ 6N~ AOther current assets~ 6~ R! Total current assets~ Um%~  @5544330000     l  O9  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!Item 701 Regulation FD Disclosu EXHIBIT INDEX Balance SheetCONSOLIDATED BALANCE SHEETS Cash FlowsCONSOLIDATED BALANCE (1)U } } $      TherapeuticsMD, Inc. 8-K 11/06/2017Income Statement-%THERAPEUTICSMD, INC. AND SUBSIDIARIES- %CONSOLIDATED STATEMENTS OF OPERATIONS  (Unaudited)   $ ____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/$,{o> =PF0*8X> @*   l  &RT  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!Item 701 Regulation FD Disclosu EXHIBIT INDEX Balance SheetIncome Statement Cash FlowsCONSOLIDATED BALANCE (1)U } -} $ }  } $ } y}  $ } y} $ } y} $ &     TherapeuticsMD, Inc. 8-K 11/06/2017#CONSOLIDATED BALANCE SHEETSThree Months Ended  Nine Months Ended    September 30,   September 30,  ~  ~  ~  ~                    Revenues, net ~    ~ Q  ~ N  ~ ~  Cost of goods sold  ~ :*   ~ K   ~ |   ~ v(  Gross profit~ ~ W  ~  橇  ~  `Operating expenses:     *"Sales, general, and administration~ 2~   ~  `   ~ hY Research and development~  ߈~   ~  V]t  ~ vFe %Depreciation and amortization~ L~ 2x  ~  >   ~ ~%$ Total operating expense~ l~    ~  v  ~ Operating loss~ v~ *N  ~  f3  ~        Other income:     Miscellaneous income~ 6 ~ ڵ  ~  J  ~ ^:Accreted interest ?~ N&  ~  Nx  ~ z Total other income~ 6 ~ &  ~  w  ~ Loss before taxes~ ~ N*   ~    ~ A"Provision for income taxes ? ?    ?   ?Net loss~ ~ N*  ~    ~ A-%Net loss per share, basic and dilutedQ뱿p= ף  HzGѿ  (\տ     )!Weighted average number of common     Dul|pd;o#7FVt3I !"#$%  shares outstanding  ~ 1   ~ ތ.   ~ ~^w0   ~ . !"$#____________________________1$)Created by Morningstar Document Research.0%(http://documentresearch.morningstar.com/ d =PF0*8X> @%%$$##            l  Z  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!Item 701 Regulation FD Disclosu EXHIBIT INDEX Balance SheetIncome StatementCONSOLIDATED BALANCE SHEETSCONSOLIDATED BALANCE (1)U }       TherapeuticsMD, Inc. 8-K 11/06/2017 Cash Flows-%THERAPEUTICSMD, INC. AND SUBSIDIARIES- %CONSOLIDATED STATEMENTS OF CASH FLOWS  (Unaudited)  $ ____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/$,uD=PF0*8X> @*   l  2 lt  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!Item 701 Regulation FD Disclosu EXHIBIT INDEX Balance SheetIncome StatementCONSOLIDATED BALANCE SHEETS Cash FlowsU } 6 Changes in operating assets and liabilities:( Accounts receivable~ 6~  Inventory~ R~ )! Other current assets~ =~ j0% Accounts payable~ ^.?~ C.& Other current liabilities~ n5~ ^*-%Net cash used in operating activities~ ~ n!=,$CASH FLOWS FROM INVESTING ACTIVITIES Patent costs~ (~ *" Purchase of fixed assets~ ~ 7Dl|pd/-;e1mV32 ! " # $ % & ' ( ) * + , - . / 0 1 %  Payment of security deposit   ?   ~ $ -!%Net cash used in investing activities!!~ !v!!!~ !L!""""""""",#$CASH FLOWS FROM FINANCING ACTIVITIES########1$) Proceeds from sale of common stock, net$$~ $nWY$$$~ $i' $%of costs,&$ Proceeds from exercise of warrants&&~ &^&&&~ &"S&+'# Proceeds from exercise of options''~ ' '''~ ';'1()Net cash provided by financing activities((~ (0N(((~ ( ()))))))))*Increase in cash**~ *f***~ *f*!+Cash, beginning of period++~ +V4\+++~ +\m+,Cash, end of period,~ ,[#,,~ ,,#,-.$/____________________________10)Created by Morningstar Document Research.01(http://documentresearch.morningstar.com/({TtsJ6v ~V=PF0*8X> @b 1100//,,,,       Root Entry FBook  u  !"#$%&'()*+,-./0123456789: